x 

0 Activities
0 Activities
    • No Saved Activities

Education

  2. Home
  3. Disease Area
  4. Pulmonary Hypertension (PH/PAH)
  5. Specialty Area
  6. Dermatology
Results 1 - 49 of 49
9483-gpp4
Rapid Recap: Immunology’s Role in GPP Pathogenesis and Therapy
9483-gpp
The IL-36 Connection: Immunology’s Role in GPP Pathogenesis and Therapy
9444 fabry
A Focus on Fabry Disease: An EXPLORE™ eLearning Module
Am I Treating My Patients With Psoriatic Disease Effectively?
Am I Treating My Patients with Psoriatic Disease Effectively?
No image set
Itching for Relief: Atopic Dermatitis Management Considerations for PAs and NPs
No image set
Practical Applications From What We Heard at Virtual ACR
No image set
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
No image set
New Directions in the Diagnosis of RA ILD
No image set
Therapies on the Horizon for RA ILD
No image set
New Treatment Options for SSc ILD
No image set
Updates on Current Treatment Options for RA ILD
No image set
Biochemical Profiles of Radiographic Patterns in SSc-ILD
No image set
Factors Associated with Disease Progression in the SENSCIS Trial
No image set
Machine Learning Assisted Prediction of Progression in SSc-ILD
No image set
What Have We Learned from Clinical Trials on Sex Differences in SSc-ILD
No image set
Efficacy of MMF in African Americans vs Non-African Americans with SSc-ILD
No image set
Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis
No image set
Updates on Current Treatment Options for RA-ILD
cc4
Interim Analysis of SENSCIS-ON TRIAL for SSc-ILD Patients Treated with Nintedanib
No image set
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
What's New in Advanced CSCC Care
The Evidence So Far: Risk, Referral, and What's New in Advanced CSCC Care
9830-icon1
Atopic Dermatitis: Diagnosis and Management in Infants and Children
9830-icon2
Updates in Atopic Dermatitis: Diagnosis and Management in Adults
No image set
Updates in Atopic Dermatitis: The Allergist’s Guide to Optimizing Care - Child
No image set
Updates in Atopic Dermatitis: The Allergist’s Guide to Optimizing Care - Adult
atopic-derm4
Atopic Dermatitis: Putting it Together (Dermatology)
atopic-derm3
Atopic Dermatitis: Putting it Together (Primary Care)
atopic-derm2 copy
Atopic Dermatitis: Recent and Emerging Therapies
atopic-derm1
An Introduction to Atopic Dermatitis
biosims-archmed icon23
Top Questions about Biosimilars in Dermatology
psoriasis-nurse
Psoriasis Management Considerations: What Would You Do?
psoriasis-case3
Jamie Develops Complications with Her Psoriasis
psoriasis-case2
Psoriasis: Three Case Studies in the Primary Care Setting
psoriasis-case1
Cindy Has a Complex Case of Psoriasis
IL-derm-case3
Switching Between Biologics: Is a Biosimilar an Option?
IL-derm-case2
When to Switch? Biologically Experienced Psoriasis Patients
IL-derm-case1
Innovator or Biosimilar for a Patient with Psoriasis
IL-fund-case4
Interchangeability and Pharmacy-Level Substitution
IL-fund-case3
FDA Criteria: Biosimilar Approval, Manufacturing, & Naming
IL-fund-case2
What is the Difference Between a Biosimilar and a Generic?
IL-fund-case1
What is a Biologic?
biosims-full
Sorting it Out: Biologics, Biosimilars, Small Molecule Drugs, and Generics
biosims-full3
Health Care Providers’ Perspectives on Biosimilars: Based in Fact or Not?
biosims-green3
Pharmacovigilance and Biosimilars: Any Special Considerations?
biosims-full5
Interchangeability and Biosimilars: What will this Mean for Clinical Practice?
biosims-green8
Can a Biosimilar be Used for the Same Indications Approved for the Reference Biologic?
biosims-full7
Biosimilars: As Safe and Effective as the Reference Product?
biosims-green
Drift and the Manufacturing of Biologics: What is it and Does it Matter?
biosims-full8
Biosimilars in Clinical Practice: Interchangeability and Extrapolation

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

10 Vista Drive, Old Lyme, CT USA

Search